|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.46/-0.28
|
Enterprise Value
32.27M
|
Balance Sheet |
Book Value Per Share
0.03
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
3.45M
|
Operating Revenue Per Share
0.04
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/01/21 05:29 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions. |